30 April 2021>: Clinical Research
Comparison of Different Hydration Strategies in Patients with Very Low-Risk Profiles of Contrast-Induced Nephropathy
Shuai Miao 1BCE , Zheng-Kai Xue 1B , Ya-Ru Zhang 1F , Hao Zhang 1A , Jing-Jin Che 1C , Tong Liu 1DF , Hua-Yue Tao 2C , Guangping Li 1AD* , Kang-Yin Chen 1ADG*DOI: 10.12659/MSM.929115
Med Sci Monit 2021; 27:e929115
Table 3 Subgroup analyses in patients receiving CAG versus PCI.
Variables | CAG | PCI | ||||||
---|---|---|---|---|---|---|---|---|
Preventive group | Remedial group | NH group | P value | Preventive group | Remedial group | NH group | P value | |
Cr, umol/L | ||||||||
Baseline | 69.08±15.06 | 59.70±11.47 | 63.03±14.50 | 0.06 | 66.51±13.49 | 68.50±16.93 | 66.10±15.43 | 0.86 |
24 h after | 67.40±15.69 | 60.40±12.90 | 64.32±16.65 | 0.26 | 66.84±14.87 | 64.26±14.05 | 67.00±16.10 | 0.80 |
72 h after | 68.95±13.51 | 64.66±15.07 | 67.05±15.40 | 0.58 | 68.39±12.63 | 67.62±12.87 | 68.44±16.14 | 0.98 |
eGFR, mL/min/1.73 m | ||||||||
Baseline | 84.54±19.57 | 98.07±21.70 | 94.43±22.67 | 0.08 | 89.60±23.47 | 86.80±26.99 | 89.94±23.51 | 0.90 |
24 h after | 92.05±22.24 | 102.88±29.32 | 97.32±26.39 | 0.34 | 94.65±22.70 | 96.29±26.97 | 93.65±22.60 | 0.94 |
72 h after | 86.62±18.46 | 96.69±27.77 | 90.05±21.04 | 0.28 | 89.17±19.86 | 89.17±21.21 | 91.09±22.96 | 0.94 |
Cys C, mg/L | ||||||||
Base line | 0.77±0.13 | 0.69±0.13 | 0.69±0.13 | 0.06 | 0.81±0.11 | 0.78±0.14 | 0.79±0.16 | 0.71 |
24 h after | 0.71±0.11 | 0.64±0.13 | 0.66±0.14 | 0.15 | 0.75±0.10 | 0.70±0.13 | 0.74±0.17 | 0.49 |
72 h after | 0.73±0.10 | 0.67±0.14 | 0.67±0.14 | 0.20 | 0.77±0.11 | 0.72±0.13 | 0.73±0.15 | 0.46 |
NGAL, ng/mL | ||||||||
Base line | 11.18±9.24 | 5.33±4.75 | 9.38±7.45 | 0.04 | 8.52±7.91 | 11.45±8.95 | 8.37 ±7.84 | 0.37 |
6 h after | 7.35±7.36 | 3.70±4.04 | 7.17±7.28 | 0.13 | 5.97±6.15 | 6.45±7.23 | 5.51±4.54 | 0.98 |
48 h after | 9.26±8.17 | 4.51±4.41 | 8.26±7.99 | 0.18 | 7.51±8.90 | 7.28±6.97 | 7.73±7.35 | 0.54 |
Cr – creatinine; eGFR – estimated glomerular filtration rate; Cys C – serum cystatin C; NGAL – neutrophil gelatinase associated lipocalin. |